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Summary The high prevalence of sleep-disordered breathing (SDB) in hyperten-
sive patients has been well studied. However, regular screening of SDB in these
patients is not performed routinely as the diagnostic procedures are both time-
consuming and labour-intensive. Overnight portable device screening is useful, but
is sometimes not acceptable for asymptomatic SDB patients. We evaluated the use-
fulness of daytime 30-min recording with a portable recording device during pulse
wave velocity (PWV) measurement sessions as a screening method for detection of
asymptomatic SDB in hypertensive patients. Eighty-one hypertensive patients under-
went 30-min daytime screening session using a Type III portable recording device
during PWV measurement. Each screening session was followed by full overnight
Level I polysomnography (PSG). The screening session included recordings of airﬂow
(mouth—nose), chest movement, oximetry, and electrocardiography. The correla-
tion coefﬁcient between respiratory disturbance index (RDI) by screening session
and apnea—hypopnea index (AHI) by PSG was 0.64. Using AHI ≥30 as diagnostic of
severe SDB, 47 of 80 patients had the disorder based on PSG results. Using an RDI
cut-off value of 22, the sensitivity and speciﬁcity for detection of severe SDB were
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86.1% and 64.5%, respectively. Daytime 30-min recording with a portable device for
apnea detection during PWV recording is useful for screening of asymptomatic severe
SDB in hypertensive patients.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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for PWV measurement were set during this period
with the patients in the supine position. Airﬂow
(mouth—nose), oximetry (SpO ), chest movement,© 2008 Japanese Colleg
reserved.
Introduction
Sleep-disordered breathing (SDB) is commonly
observed in patients with cardiovascular prob-
lems, especially in hypertensive patients [1]. A
diagnosis of obstructive sleep apnea syndrome
(OSA) is made in SDB patients with subjective
symptoms including excessive daytime sleepiness.
Overnight full polysomnography (PSG) is performed
in such symptomatic patients to measure multi-
ple biological parameters during sleep, and when
applicable, nasal continuous positive airway pres-
sure (nCPAP) may be prescribed. However, for a
number of reasons identiﬁcation and diagnosis of
SDB are not routinely performed in patients with
cardiovascular problems. First, standard treatment
for asymptomatic SDB has yet to be established
[2]. Although nCPAP treatment is effective to
decrease the blood pressure in symptomatic OSA
patients, it has been reported to be ineffective
for asymptomatic SDB patients [3]. Second, the
standard PSG, the diagnostic method for SDB/OSA,
is both time-consuming and labour-intensive and
requires overnight hospitalization. Due to the lack
of apparent beneﬁt, many asymptomatic patients
are reluctant to undergo time-consuming PSG.
Moreover, the number of institutions that per-
form PSG on a regular basis is limited. Recently,
numerous portable recording systems have been
developed for OSA screening. These systems uti-
lize small devices with limited recording channels,
and the examination does not require hospital-
ization but one overnight home recording [4—7].
However, screening of SDB in hypertensive patients
is still difﬁcult even utilizing such portable devices.
Hypertensive patients are usually asymptomatic,
and the overnight examination is still unacceptable
for many patients.
On the other hand, many studies have indi-
cated a high incidence of cardiovascular problems
in SDB patients [8]. Untreated OSA patients are
known to have high mortality rates [9]. The mor-
tality in asymptomatic SDB patients has not yet
been clariﬁed, because available data for severity
of SDB are largely from sleep laboratories where the
patients are symptomatic. Although the standard
treatment has not yet been established, severity
evaluation of SDB in patients with cardiovascular
b
i
(
troblems is necessary for risk stratiﬁcation. Sim-
le methods for screening and evaluating SDB in
ypertensive patients are urgently needed for their
outine management. Based on the observation
f frequent snoring and apnea during the 30-min
essions for pulse wave velocity (PWV) measure-
ent reported by technicians, we propose a new
ethod for screening of SDB. For the new screening
ethod, we measured airﬂow and oxygen satu-
ation in hypertensive patients during a 30-min
est period in a quiet room during the day. PWV
easurements are commonly performed for hyper-
ensive patients, and they will likely readily accept
he additional simultaneous measurements. In the
resent study, we evaluated the validity of the new
creening method to detect SDB and an appropriate
ut-off level was suggested.
ethods
atients receiving care for primary hyperten-
ion from the Cardiology Department of Teikyo-
niversity Hospital were eligible for screening
easurement. Patients undergoing pulse wave
elocity (PWV) recording between 1 September
004 and 30 December 2006 were asked for
ermission to perform the simultaneous apnea
creening measurements described in the next
ection. Informed consent was obtained from all
atients prior to enrolling in the study in accor-
ance with the instructions of the institutional
thical committee. Each patient completed the
pworth Sleepiness Scale (ESS) to assess and quan-
ify daytime sleepiness.
creening session
nrolled patients reclined on a comfortable bed
or about 30min in an ambient-quiet room prior
o measurement of PWV. Brachial and ankle cuffs2
ronchial sound, and electrocardiogram were mon-
tored using a type III portable recording device
FM-500; Fukuda Denshi, Tokyo, Japan) throughout
he session. In accordance with the manufacturer’s
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Table 1 Patient Demographics.
Screening Full PSG p
n 289 81
Male/female 141/148 51/30 N.S.
Age 65.7± 10.3 64.9± 9.6 N.S.
ESS 5.6± 3.6 6.5± 4.1 N.S.
BMI 25.5± 4.2 25.9± 4.3 N.S.
BP (mmHg)
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nstructions, the qualities of recordings were
udged by airﬂow signal amplitude indicated on
he display attached to the device. Data were
nalyzed with an SCM-6000 workstation (Fukuda
enshi) by semi-auto measurement and manual
diting. One laboratory technician observed both
he patient and the recording conditions during
he session. The technician also recorded whether
he patient snored for more than 10 s during the
ession. The snoring was conﬁrmed by bronchial
ound recording afterward. If no snoring was
bserved, the patients were asked whether they
ell sleep during the session and their responses
ere recorded.
In accordance with the analysis software pro-
ided by the manufacturer of the airﬂow monitor,
pnea and hypopnea were deﬁned as follows. Apnea
as identiﬁed when a nearly ﬂat airﬂow (<10% of
aseline, at which the baseline amplitude was iden-
iﬁed during the nearest preceding period of regular
reathing with stable oxygen saturation) for at least
0 s was observed. Hypopnea was identiﬁed when
n airﬂow of approximately <70% of the baseline for
t least 10 s followed by oxygen desaturation events
as observed. The oxygen desaturation event was
escribed as percentage arterial oxygen satura-
ion (SpO2) decrease >3% lasting more than 10 s.
pnea—hypopnea index (AHI) was deﬁned as the
umber of apnea and hypopnea events per hour of
leep, and the value could not be obtained with-
ut actual sleeping time. In this screening session,
e determined the respiratory disturbance index
RDI) [5]. The value was deﬁned as the number of
pnea and hypopnea events per hour of monitor-
ng time. We recommended full PSG for all patients
ndergoing the screening session.
PWV measurements were performed at the end
f the screening session. Bilateral brachial and
nkle cuffs were used for measurement of blood
ressure and pulse wave analysis (Form PWV/ABI;
olin Medical Technology, Tokyo, Japan). The sys-
olic and diastolic blood pressures presented in this
tudy were brachial blood pressures measured using
his device.
olysomnography
vernight PSG was performed 4—8 weeks after
he screening session at the university hospital
r in an adjacent sleep laboratory. A standard
xamination was performed using two electroen-
ephalogram (EEC) channels, two electrooculogram
EOG) recordings with a reference, one submen-
al electromyogram (EMG), one electrocardiogram
ECG) lead for heart rate, and one intercostal
MG for respiratory effort. Respiration was moni-
a
i
e
f
mSystolic 131.3± 15.8 128.8± 15.5 N.S.
Diastolic 77.8± 10.6 78.1± 11.1 N.S
ored by recording thoracic and abdominal effort
sing piezoelectric sensors, and oronasal ﬂow was
etermined with a thermistor. Snoring sounds were
ecorded using a microphone connected to an
mpliﬁer, and body position was checked by video
ecording. SpO2 was detected using a ﬁnger probe
ximeter. PSG paper speed was set at 10mm/s to
llow correct sleep staging. Apnea was identiﬁed
y a nearly ﬂat airﬂow (<10% of baseline, at which
he baseline amplitude was identiﬁed during the
earest preceding period of regular breathing with
table oxygen saturation) for at least 10 s. Hypop-
ea was identiﬁed as airﬂow or thoracoabdominal
xcursion of approximately <70% of baseline for at
east 10 s associated with either oxygen desatura-
ion of >3% or arousal.
valuation of validity and determination of
ut-off level
o evaluate the validity of the new screening
ethod, its sensitivity and speciﬁcity to detect SDB
ith overnight PSG as the gold standard was deter-
ined at various RDI. From this, an appropriate RDI
ut-off to obtain high sensitivity and acceptable
peciﬁcity was proposed.
esults
wo hundred and eighty-nine patients gave their
nformed consent to allow the recording for
creening (141 men and 148 women). Background
haracteristics of the patients are summarized in
he left part of Table 1. Mean ESS scale was less than
, and the majority of the patients were free from
xcessive daytime sleepiness. All of the patients
ere taking at least one anti-hypertensive drug,
nd blood pressure at the time of PWV record-
ng was within the normal limit. Fig. 1 shows an
xample of an apnea episode in a 71-year-old
emale patient. Mouth—nose airﬂow, chest move-
ent, and oxygen saturation curves are shown.
82 T. Furukawa et al.
Figure 1 A representative recording of screening session in a 71-year-old female. Upper Panel: 6min recording showing
mouth—nose airﬂow, chest movement, heart rate, and oxygen saturation curves are shown. Gray markers denote the
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capnea—hypopnea events and desaturation events. Apnea
obvious. Lower Panel: entire recording showing mouth—
curves (left side). 18 apnea—hypopnea episodes are obse
Apnea episodes and subsequent desaturation (>3%)
episodes were obvious even in the short 30-min
recording session. Her ESS was 4 points and she did
not realize that she had fallen asleep, but exam-
iners noted snoring. During this recording session
of 30.8min, 16 apnea—hypopnea episodes and 5
desaturation episodes were detected. Thus, RDI
was calculated to be 31.0. The average value of RDI
in all patients was 13.7± 17.4/h. One hundred and
three patients (35.6%) reported subjective sleep
during the session, and snoring was noted in 144
patients (49.8%). A total of 150 patients (51.9%)
showed signs of sleep. ESS was ≥9 in 78 patients
T
a
m
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Table 2 Sensitivity and Speciﬁcity for Screening of Severe
RDI Cut-off Sensitivity% (95%CI), positive case
≥30 72 (56—85), 31
≥25 77 (61—88), 33
≥23 79 (64—90), 34
≥22 86 (72—95), 37
≥20 88 (75—96), 38
a SDB n = 43 AHI≥ 30.
b Non-SDB n = 31 AHI < 30.odes and subsequent desaturation (<90%) episodes were
airﬂow (right side), heart rate, and oxygen saturation
.
27.0%), and RDI was ≥5 in 147 patients (51.0%).
he background characteristics of these patients
re also shown in Table 1.
Among the hypertensive patients who under-
ent the screening session, 81 (28.0%) consented to
ndergo full overnight PSG. Seven of these subjects
ere excluded from the analysis—–one because they
id not have hypertension and 6 for whom techni-
al problems occurred during the screening session.
hese patients almost exclusively had obstructive
pneas, except two cases had central components
ore than 10% (10.8% and 15.2%). The average of
entral component was 1.3± 2.6% of total apnea
SDB.
sa Speciﬁcity% (95%CI), negative casesb
90 (74—98), 28
81 (63—93), 25
71 (52—86), 22
65 (45—81), 20
61 (42—78), 19
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Figure 2 Panel A: relationships between RDI by the
new screening method and AHI by full PSG. Horizontal
dashed line denotes the severe SDB level of AHI 30. Ver-
tical dashed line denotes the proposed RDI cut off level
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Figure 3 Receiver operating characteristic (ROC) curve
for severe SDB screening at various RDI cut-off levels. The
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ing. However, the recordings can be obtained duringf 22. Correlation coefﬁcient was 0.64 (P < 0.001). B:
land—Altman plot for RDI and AHI.
pisodes. The characteristics of the patients who
nderwent PSG are summarized on the right hand
ide of Table 1. The RDI value in these patients was
3.9± 16.7%, and the value was signiﬁcantly higher
han that of patients who did not undergo PSG
9.2± 15.9%; P < 0.01). Fig. 2 illustrates the rela-
ionships between RDI by the new screening method
nd AHI by full PSG. Panel A in Fig. 2 shows that the
orrelation coefﬁcient was 0.64 (P < 0.001). Panel B
hows a Bland—Altman plot of the two parameters.
he estimated mean difference was 7.9 and the
.D. was 13.9. Sensitivity and speciﬁcity for detec-
ion of severe SDB (AHI ≥30) at various RDI levels
ere estimated, and are summarized in Fig. 3 (ROC
urve) and Table 2. With regard to the most appro-
riate combination of sensitivity and speciﬁcity,
n RDI cut-off value of 22 was suggested, where
ensitivity and speciﬁcity were 86.1% and 64.5%,
espectively. With this cut-off value, the positive
nd negative predictive values were calculated as
7.1% and 76.9%, respectively.
a
s
Trrow denotes the suggested RDI cut-off level. See text
nd Table 2 for detail.
iscussion
s patients with cardiovascular problems have been
hown to have a high prevalence of SDB [2], many
hysicians and cardiologists have recognized SDB
nd sleep apnea syndrome as major problems that
romote various complications [10,11]. Although
he high prevalence of SDB was reported in west-
rn countries, a similar high incidence is also
bserved in Japan [12,13]. Data regarding the car-
iovascular risk of SDB are most convincing for
ypertension [1,14]. Nonetheless, routine evalua-
ion of SDB is not common in hypertensive patients.
n the present study, we proposed a simple screen-
ng method for SDB in hypertensive patients, and
valuated its validity. The plots in Fig. 2 show a
igniﬁcant correlation between RDI and AHI val-
es. Although the Bland—Altman plots showed that
here was a tendency to underestimate AHI by
he screening method, the performance of our
creening methods were satisfactory with a high
egree of sensitivity of about 86%, while maintain-
ng moderate speciﬁcity of 65%. Another advantage
f this method was that the asymptomatic patients
howed good acceptance of the full PSG after actual
ecording of their own apnea episodes.
We used a type III portable recording device
nder attended conditions in this study, which was
rather heavily equipped method for SDB screen-daytime outpatient hospital visit, and the time
pan for recording was limited to about 30min.
he total session could be completed in about
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45—60min including preparations, which was much
simpler than ordinal SDB screening with overnight
recording. In a review [5] of overnight record-
ings, the sensitivity and speciﬁcity of the screening
method with portable devices were reported to
be 60—100% and 20—100%, respectively, although
the values were variable depending on the device
and recording situation. We consider the sensitiv-
ity of our method acceptable compared to previous
reports. We do not propose use of this screen-
ing method as a replacement for full PSG. The
value of PSG for evaluation of SDB patients is
well established, and the necessity of PSG should
be further evaluated by large-scale clinical trials.
The goal of the present study was to effectively
detect asymptomatic hypertensive patients with a
high possibility of severe SDB, and provide suitable
treatment options for these patients.
The study design described here had some
limitations. Although we performed screening ses-
sions with unselected hypertensive patients, not
all patients accepted the full PSG. This may have
caused some bias in case selection for PSG. The
sensitivity and speciﬁcity presented in this study
were those for 81 of 289 hypertensive patients. The
patient demographics of all cases and in the cases
that accepted the full PSG were similar with the
exception of the ESS score (Table 1); ESS scores in
patients who accepted the PSG study tended to be
higher than that of the total patient population,
although the difference was not statistically signiﬁ-
cant. These observations may contribute to the high
incidence of severe SDB in the patients who con-
sented to the full PSG study. If it had been possible
to perform the full PSG study in all patients, it may
have resulted in higher speciﬁcity of the screening
methods by including subjects without severe SDB.
However, the PSG study was not performed with-
out the screening session. Detection of 47 patients
with severe SDB in the total of 298 hypertensive
patients (15.8%) would have an impact on daily
clinical treatment. Thus, we concluded that day-
time 30-min recording with a portable device for
apnea detection during PWV recording is useful for
asymptomatic severe SDB screening in hypertensive
patients.
The mortality rate in moderate to severe sleep
apnea syndrome is known to be high [9,10,15], and
nCPAP has already been shown to have beneﬁcial
effects on long-term prognosis [16]. However, all
these lines of evidence were provided by surveys
performed in sleep laboratories and the patients
were therefore symptomatic. Excessive daytime
sleepiness has been proposed as a cause of hyper-
tension in patients with sleep apnea syndrome
[1], because it may stimulate sympathetic activityT. Furukawa et al.
nd the rennin—angiotensin—aldosterone system.
herefore, nCPAP effectively reduced the blood
ressure in symptomatic OSA patients with hyper-
ension [17]. However, nCPAP did not improve the
lood pressure or subjective symptoms after 1
onth in asymptomatic SDB patients [3]. A large
ulti-center study is currently underway to exam-
ne the outcomes after 6 months of therapy [2] to
onﬁrm the usefulness of nCPAP in asymptomatic
DB patients with hypertension. It will be neces-
ary to await the results to determine whether
e can apply nCPAP to hypertensive patients with
symptomatic SDB. An interesting ﬁnding regard-
ng the problem in the present study was that
ore than half of our patients slept during the
ery short screening session despite their lack of
aytime sleepiness. Although subjective sleepiness
ssessed by ESS score was almost absent in our
atients, the results suggested many hypertensive
atients were unaware of their own sleepiness. In
he patients undergoing full PSG, 47 cases (58%) had
evere SDB (AHI >30). Although the ESS scores in
hese patients were not high as shown in Table 1, we
ould not determine whether these patients were
ruly asymptomatic. The effectiveness and compli-
nce of nCPAP therapy in these patients should be
xamined in future studies.
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